An investment group few people in Australian insurance had heard of until this week says it wants to buy one of the country’s listed life companies. It hasn’t said which one.
The NEXROC Group describes itself as an alternative asset manager and diversified holding company, with addresses in New York and Tokyo. It has announced plans to make offers for two publicly listed life insurers, one in Australia and one in the United States. Talks with each target’s board and management were due to start on 12 October. The group intends to launch an off-market takeover offer for the Australian company, and a tender offer for the US one, by 10 November.
NEXROC says it is seeking friendly deals and is open to negotiating with the targets’ boards and management. Neither target has been named. No listed life company had made an announcement to the ASX at the time of writing.
If the deals go ahead, both insurers would be folded into NEXLIFE Group, NEXROC’s insurance arm. They would keep operating on a standalone basis with access to the parent’s capital. NEXROC calls the purchases the first stage of a roll-up strategy beginning next year. Its goal is to lock in long-duration liabilities to back its asset origination business. That is the familiar logic of treating life insurance balance sheets as patient capital. According to the group’s own website, its planned structure also includes a reinsurance vehicle and an annuities platform.
Read next: Why global insurers are rebuilding their life insurance books
Until earlier this year the group traded as NextRock Investment Group. It lists David Liu as interim chief executive. Its interests go well beyond insurance and include asset management, real estate, an AI platform, and a set of what it calls cultural and consumer brands.
Private markets database PitchBook lists the company as privately held and venture-backed, founded in 2025, with a most recent funding round of US$25 million. That is small change next to the price of a listed insurer. NEXROC has not said how it would pay for either acquisition.
Its interest in Australia was signalled last month. On 19 September it posted a release titled “NEXROC Eyes Australian Companies for Its Global Asset Management Platform”. The page still carries only a single line saying the full announcement is coming soon.
Buying an Australian life insurer is not quick. Under the Financial Sector (Shareholdings) Act, nobody can hold more than 20% of an insurer without the Treasurer’s approval, as the Australian Prudential Regulation Authority has explained.
Approval above that threshold depends on a national interest test, which includes competition considerations. APRA will also want to know where the money is coming from and who ultimately controls it. A foreign bidder would also expect scrutiny from the Foreign Investment Review Board, and potentially the ACCC.
There is also a deadline. Under section 631 of the Corporations Act, anyone who publicly proposes a takeover bid must make offers within two months. Failing to do so is an offence.
The rule is enforced. In June this year, Palmer Leisure Coolum, the Clive Palmer-linked company, pleaded guilty to breaching it, following an ASIC investigation into a 2012 bid that never went ahead.
Read next: Zurich lands ClearView, adding a third brand to its life insurance stable
Whoever NEXROC has in mind, there are fewer ASX-listed life insurers than a year ago. Zurich Financial Services Australia completed its roughly $385m acquisition of ClearView Wealth on 20 August, paying 60 cents a share. ClearView shareholders had backed the scheme overwhelmingly in July. Research house Dexx&r estimates the deal gives Zurich close to 23% of the advised life market. TAL remains the biggest player overall, with around 30% of total premium.
All four of Australia’s largest life insurance groups now answer to overseas parents. The most recent big reshuffle came when Nippon Life brought Resolution Life Australasia and MLC Life together under the Acenda brand.
Read next: Life insurance giants merge to form regional powerhouse
The next four weeks should settle a lot. If talks are underway, a target board may confirm an approach to the market. If not, NEXROC’s 10 November deadline will show whether this is a serious bid or an ambitious press release
